EUVIMEDEUVIMED entdecken
Crossref

Preventive effect of MitoQ supplementation and endurance training on glioblastoma and its consequences: TLR4/CREB/ NF-κβ /IL-1β pathway and behaviors

Soheil Aminizadeh, Amir Hossein Moslemizadeh, Sara Sheibani, Zahra Sedighi-Khovidak, Zahrasadat Roholamini, Saeideh Jafarinejad-Farsangi, Reza Kheirandish, Vahid Sheibani, Hamideh Bashiri

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2024.113756 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Soheil Aminizadeh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Glioblastoma, Rats, Wistar, Ubiquinone. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 112 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The present study investigated the preventive effect of MitoQ supplementation and endurance training (ET) on the TLR4/CREB/ NF-κβ signaling pathway, antioxidant indices, and behaviors in C6-induced glioblastoma (GBM) in rats. METHODS: 60 male Wistar rats were randomly divided into five groups (n = 12); Sham, Tumor, MitoQ, ET, and MitoQ + ET. Rats in the training groups performed endurance training (5 days per week), and MitoQ at the dose of 250 µM/L daily was administered in drinking water for 8 weeks. At the end of the protocol, all groups except the sham group received 1*106 tumor cells /10 µl culture medium. Two weeks after tumor induction, behavioral tests were performed, and then brain tissue was collected for the histopathology, measurement of antioxidant and inflammatory factors, TLR4, NF-κB proteins, and TLR4, NF-κβ, CREB, IL-1ß, TNF-a, IL-10, Bax, Bcl-2, and Caspase-3 gene expression. RESULTS: The increased level of TLR4 and NF-κβ protein expression in GBM rats decreased in the treatment groups. Gene expression of TLR4, NF-κβ, CREB, TNF-a, IL-10, and Bcl-2 increased in the tumor groups, and treatment groups decreased TLR4, NF-κB, Bcl-2, and CREB. In addition, social behaviors, balance, and memory were impaired in the tumor group, which combination group could improve these behaviors. CONCLUSION: In sum, the preventive effects of MitoQ as a beneficial immune reactive agent and exercise training in rats with C6-induced glioblastoma may be mediated via modulating oxidative stress, inflammatory factors, and down-regulation of the expression of TLR4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4GlioblastomaRats, WistarUbiquinoneNF-kappa BOrganophosphorus CompoundsSignal TransductionInterleukin-1betaAnimalsMaleRatsEndurance TrainingPhysical Conditioning, AnimalCyclic AMP Response Element-Binding ProteinBrain NeoplasmsBehavior, AnimalAntioxidantsCell Line, TumorHumansDietary Supplements

Stichwörter der Autor:innen

BehaviorsEndurance trainingGlioblastomaMitoQ supplementationNF-κβTLR4

Substanzen

Toll-Like Receptor 4UbiquinoneNF-kappa BOrganophosphorus CompoundsTlr4 protein, ratmitoquinoneInterleukin-1betaCyclic AMP Response Element-Binding ProteinAntioxidantsCreb1 protein, rat

Autor:innen und Institutionen

  • Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
  • Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Behavioral and Molecular Neurobiology, Regensburg Center for Neuroscience, University of Regensburg, Regensburg, Germany.
  • Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, Shahid Bahonar University of Kerman, Kerman, Iran.
  • Department of Pathology, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran.
  • Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.

Zitieren

APA

Aminizadeh, S., Moslemizadeh, A. H., Sheibani, S., Sedighi-Khovidak, Z., Roholamini, Z., Jafarinejad-Farsangi, S., Kheirandish, R., Sheibani, V., & Bashiri, H. (2025). Preventive effect of MitoQ supplementation and endurance training on glioblastoma and its consequences: TLR4/CREB/ NF-κβ /IL-1β pathway and behaviors. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113756

Vancouver

Aminizadeh S, Moslemizadeh AH, Sheibani S, Sedighi-Khovidak Z, Roholamini Z, Jafarinejad-Farsangi S, et al. Preventive effect of MitoQ supplementation and endurance training on glioblastoma and its consequences: TLR4/CREB/ NF-κβ /IL-1β pathway and behaviors. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2024.113756

BibTeX
@article{Aminizadeh2025,
  author = {Aminizadeh, Soheil and Moslemizadeh, Amir Hossein and Sheibani, Sara and Sedighi-Khovidak, Zahra and Roholamini, Zahrasadat and Jafarinejad-Farsangi, Saeideh and Kheirandish, Reza and Sheibani, Vahid and Bashiri, Hamideh},
  title = {Preventive effect of MitoQ supplementation and endurance training on glioblastoma and its consequences: TLR4/CREB/ NF-κβ /IL-1β pathway and behaviors},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2024.113756}
}
Kostenlos starten →